Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates

Microbial Drug Resistance

Volumn 18, Issue 1, 2012, Pages 23-32

  Pasca, Maria Rosalia ^a   Dalla Valle, Claudia ^a   De Jesus Lopes Ribeiro, Ana Luisa ^a,b   Buroni, Silvia ^a   Papaleo, Maria Cristiana ^c   Bazzini, Silvia ^a   Udine, Claudia ^a   Incandela, Maria Loreto ^a   Daffara, Silvio ^a   Fani, Renato ^c   Riccardi, Giovanna ^a   Marone, Piero ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BACTERIAL PROTEIN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESISTANCE NODULATION CELL DIVISION PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONAL SPECIES; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CODE; ITALY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; REGULATOR GENE; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA GYRASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REGULATOR; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONAS AERUGINOSA; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

PSEUDOMONAS AERUGINOSA;

EID: 84856707767     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0019     Document Type: Article

References (38)

1. Adewoye, L., A. Sutherland, R. Srikumar, and K. Poole. 2002. The mexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutations compromising activity. J. Bacteriol. 184:4308-4312. (Pubitemid 34774314)
2. Akasaka, T., M. Tanaka, A. Yamaguchi, and K. Sato. 2001. Type II topoisomerase mutations in fluoroquinoloneresistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob. Agents Chemother. 45:2263-2268. (Pubitemid 32664465)
3. Alibert-Franco, S., B. Pradines, A. Mahamoud, A. Davin-Regli, and J.M. Pagès. 2009. Efflux mechanism, an attractive target to combat multidrug resistant Plasmodium falciparum and Pseudomonas aeruginosa. Curr. Med. Chem. 16:301-317.
4. Baum, E.Z., S.M. Crespo-Carbone, B.J. Morrow, T.A. Davies, B.D. Foleno, W. He, A.M. Queenan, and K. Bush. 2009. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:2785-2790.
5. Cao, L., R. Srikumar, and K. Poole. 2004. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol. Microbiol. 53:1423-1436. (Pubitemid 39209115)
6. CLSI. 2005. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Sixth edition: approved standard M7-A6. CLSI, Wayne, PA.
7. Evans, K., L. Adewoye, and K. Poole. 2001. MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexAmexR intergenic region. J. Bacteriol. 183:807-812. (Pubitemid 32095288)
8. Falagas, M.E., and I.A. Bliziotis. 2007. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int. J. Antimicrob. Agents 29:630-636. (Pubitemid 46710354)
9. Falagas, M.E., P.K. Koletsi, and I.A. Bliziotis. 2006. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 55:1619-1629. (Pubitemid 44902023)
10. Gorgani, N., S. Ahlbrand, A. Patterson, and N. Pourmand. 2009. Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 34:414-418.
11. Higgins, P.G., A.C. Fluit, D. Milatovic, J. Verhoef, and F.J. Schmitz. 2003. Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 21:409-413. (Pubitemid 36506632)
12. Hocquet, D., P. Nordmann, F. El Garch, L. Cabanne, and P. Plésiat. 2006. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1347-1351.
13. Jeannot, K., M.L. Sobel, F. El Garch, K. Poole, P. Plesiat. 2005. Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction. J. Bacteriol. 187:5341-5346. (Pubitemid 41022953)
14. Johansen, H.K., S.M. Moskowitz, O. Ciofu, T. Pressler, and N. Høiby. 2008. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J. Cyst. Fibros. 7:391-397.
15. Köhler, T., S.F. Epp, L.K. Curty, and J.C. Pechère. 1999. Characterization of MexT, the regulator of the MexE-MexFOprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 181:6300-6305.
16. Kugelberg, E., S. Löfmark, B. Wretlind, and D.I. Andersson. 2005. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 55: 22-30. (Pubitemid 40192610)
17. Lee, Y.C., B.J. Ahn, J.S. Jin, J.U. Kim, S.H. Lee, Y. Song do, W.K. Lee, and J.C. Lee. 2007. Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea. J. Microbiol. 45:358-363.
18. Levine, C., H. Hiasa, and K.J. Marians. 1998. DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim. Biophys. Acta 1400:29-43. (Pubitemid 28475094)
19. Lomovskaya, O., M.S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V.J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116. (Pubitemid 32039101)
20. Maniati, M., A. Ikonomidis, P. Mantzana, A. Daponte, A.N. Maniatis, and S. Pournaras. 2007. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J. Antimicrob. Chemother. 60: 132-135. (Pubitemid 47073286)
21. Maseda, H., H. Yoneyama, and T. Nakae. 2000. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:658-664. (Pubitemid 30117958)
22. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Contribution of the MexXMexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:2242-2246. (Pubitemid 30650862)
23. Matsuo, Y., S. Eda, N. Gotoh, E. Yoshihara, and T. Nakae. 2004. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol. Lett. 238:23-28. (Pubitemid 39164526)
24. Matthaiou, D.K., A. Michalopoulos, P.I. Rafailidis, D.E. Karageorgopoulos, V. Papaioannou, G. Ntani, G. Samonis, and M.E. Falagas. 2008. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit. Care Med. 36:807-811.
25. McCay, P.H., A.A. Ocampo-Sosa, and G.T. Fleming. 2010. Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture. Microbiology 156:30-38.
26. Mesaros, N., P. Nordmann, P. Plésiat,M. Roussel-Delvallez, J. Van Eldere, Y. Glupczynski, Y. Van Laethem, F. Jacobs, P. Lebecque, A.Malfroot, P.M. Tulkens, and F. Van Bambeke. 2007. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin. Microbiol. Infect. 13:560-578. (Pubitemid 46730662)
27. Mori, E., P. Liò, S. Daly, G. Damiani, B. Perito, and R. Fani. 1999. Molecular nature of RAPD markers from Haemophilus influenzae Rd genome. Res. Microbiol. 150:83-93.
28. Morita, Y., M.L. Sobel, and K. Poole. 2006. Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product. J. Bacteriol. 188:1847-1855. (Pubitemid 43346863)
29. Mouneimné, H., J. Robert, V. Jarlier, and E. Cambau. 1999. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:62-66. (Pubitemid 29069200)
30. Poole, K., N. Gotoh, H. Tsujimoto, Q. Zhao, A. Wada, T. Yamasaki, S. Neshat, J. Yamagishi, X.Z. Li, and T. Nishino. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21:713-724. (Pubitemid 26281520)
31. Quale, J., S. Bratu, J. Gupta, and D. Landman. 2006. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 50:1633-1641.
32. Rossolini, G.M., and E. Mantengoli. 2005. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin. Microbiol. Infect. 11:17-32. (Pubitemid 40946169)
33. Sekiguchi, J., K. Teruya, K. Horii, E. Kuroda, H. Konosaki, Y. Mizuguchi, M. Araake, A. Kawana, H. Yoshikura, T. Kuratsuji, H. Miyazaki, and T. Kirikae. 2007. Molecular epidemiology of outbreaks and containment of drugresistant Pseudomonas aeruginosa in a Tokyo hospital. J. Infect. Chemother. 13:418-422. (Pubitemid 350308163)
34. Sobel, M.L., D. Hocquet, L. Cao, P. Plesiat, and K. Poole. 2005. Mutations in PA3574 (nalD) lead to increased MexABOprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:1782-1786. (Pubitemid 40631589)
35. Srikumar, R., C.J. Paul, and K. Poole. 2000. Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 182:1410-1414. (Pubitemid 30104421)
36. Takenouchi, T., E. Sakagawa, and M. Sugawara. 1999. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones. Antimicrob. Agents Chemother. 43:406-409. (Pubitemid 29079186)
37. Westfall, L.W., N.L. Carty, N. Layland, P. Kuan, J.A. Colmer-Hamood, and A.N. Hamood. 2006. mvaT mutation modifies the expression of the Pseudomonas aeruginosa multidrug efflux operon mexEF-oprN. FEMS Microbiol. Lett. 255:247-254.
38. Wolter, D.J., E. Smith-Moland, R.V. Goering, N.D. Hanson, and P.D. Lister. 2004. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diagn. Microbiol. Infect. Dis. 50:43-50. (Pubitemid 39360261)